https://health.economictimes.indiatimes.com/news/industry/those-at-high-risk-of-mpox-should-get-2-doses-of-bavarian-nordic-vaccine-us-cdc-says/100347702
0
0
5/19/23 at 6:03am
Organization
The Times of India
Author
ET HealthWorld
67 words
0
Comments
The study of the vaccine's real-world use, conducted between Aug. 19, 2022 and March 31, 2023 among 917 people, showed it was 85.9 per cent effective overall in preventing disease after two doses, compared with 75.2 per cent after one dose. For people in the …
You are the first to view
Create an account
or login to join the discussion